S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Bargain in Today's Market (SHOCKING) (Ad)pixel
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Most profitable less than $5 stock in the world? (Ad)pixel
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Bargain in Today's Market (SHOCKING) (Ad)pixel
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Most profitable less than $5 stock in the world? (Ad)pixel
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Bargain in Today's Market (SHOCKING) (Ad)pixel
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Most profitable less than $5 stock in the world? (Ad)pixel
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Bargain in Today's Market (SHOCKING) (Ad)pixel
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Most profitable less than $5 stock in the world? (Ad)pixel
NYSE:GMRE

Global Medical REIT - GMRE Stock Forecast, Price & News

$11.75
-0.03 (-0.25%)
(As of 08/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$11.72
$11.94
50-Day Range
$10.73
$13.22
52-Week Range
$10.50
$18.51
Volume
231,933 shs
Average Volume
416,548 shs
Market Capitalization
$769.84 million
P/E Ratio
61.85
Dividend Yield
7.13%
Price Target
$16.50

Global Medical REIT MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
40.4% Upside
$16.50 Price Target
Short Interest
Healthy
8.46% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-3.19
Upright™ Environmental Score
News Sentiment
-0.56mentions of Global Medical REIT in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
8.42%
From $0.95 to $1.03 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.64 out of 5 stars

Finance Sector

291st out of 1,206 stocks

Real Estate Investment Trusts Industry

68th out of 216 stocks

GMRE stock logo

About Global Medical REIT (NYSE:GMRE) Stock

Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.

Analysts Set New Price Targets

Several equities analysts recently commented on GMRE shares. JMP Securities began coverage on shares of Global Medical REIT in a report on Thursday, July 7th. They set a "market perform" rating on the stock. B. Riley lowered their price objective on shares of Global Medical REIT from $18.00 to $16.00 in a research report on Tuesday, May 10th.

Global Medical REIT Stock Up 0.8 %

Shares of GMRE traded up $0.10 during mid-day trading on Monday, hitting $11.88. The company's stock had a trading volume of 2,106 shares, compared to its average volume of 415,002. The company's 50-day moving average is $11.61 and its 200-day moving average is $14.03. Global Medical REIT has a 52-week low of $10.50 and a 52-week high of $18.51. The firm has a market capitalization of $778.35 million, a price-to-earnings ratio of 62.00, a PEG ratio of 1.56 and a beta of 0.94. The company has a current ratio of 0.12, a quick ratio of 0.12 and a debt-to-equity ratio of 0.92.

Global Medical REIT Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, July 8th. Stockholders of record on Friday, June 24th were given a $0.21 dividend. The ex-dividend date was Thursday, June 23rd. This represents a $0.84 annualized dividend and a dividend yield of 7.07%. Global Medical REIT's payout ratio is presently 442.13%.

Receive GMRE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Medical REIT and its competitors with MarketBeat's FREE daily newsletter.

GMRE Stock News Headlines

Summit Hotel Properties (INN) Misses Q2 FFO Estimates
SL Green (SLG) Q2 FFO Surpass Estimates
Global Medical REIT Inc - Stock Dividends GMRE
Global Medical REIT: Nearing Escape Velocity
Global Medical REIT (GMRE) Q1 FFO Lag Estimates
Global Medical REIT Q1 2022 Earnings Preview
Global Medical REIT (GMRE) Meets Q4 FFO Estimates
Global Medical REIT Q4 2021 Earnings Preview
See More Headlines
Receive GMRE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Medical REIT and its competitors with MarketBeat's FREE daily newsletter.

GMRE Company Calendar

Last Earnings
5/04/2022
Ex-Dividend for 7/8 Dividend
6/23/2022
Dividend Payable
7/08/2022
Today
8/09/2022
Next Earnings (Estimated)
11/02/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Real estate investment trusts
Sub-Industry
N/A
Sector
Finance
Fax
N/A
Employees
26
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$16.50
High Stock Price Forecast
$17.00
Low Stock Price Forecast
$16.00
Forecasted Upside/Downside
+40.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$17.62 million
Pretax Margin
16.03%

Debt

Sales & Book Value

Annual Sales
$115.94 million
Cash Flow
$1.04 per share
Book Value
$8.76 per share

Miscellaneous

Free Float
60,539,000
Market Cap
$769.84 million
Optionable
Optionable
Beta
0.94














GMRE Stock - Frequently Asked Questions

Should I buy or sell Global Medical REIT stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" GMRE shares.
View GMRE analyst ratings
or view top-rated stocks.

What is Global Medical REIT's stock price forecast for 2022?

2 brokers have issued 12-month price targets for Global Medical REIT's shares. Their GMRE share price forecasts range from $16.00 to $17.00. On average, they anticipate the company's share price to reach $16.50 in the next twelve months. This suggests a possible upside of 40.4% from the stock's current price.
View analysts price targets for GMRE
or view top-rated stocks among Wall Street analysts.

How has Global Medical REIT's stock price performed in 2022?

Global Medical REIT's stock was trading at $17.75 at the start of the year. Since then, GMRE stock has decreased by 33.8% and is now trading at $11.75.
View the best growth stocks for 2022 here
.

When is Global Medical REIT's next earnings date?

Global Medical REIT is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our GMRE earnings forecast
.

How were Global Medical REIT's earnings last quarter?

Global Medical REIT Inc. (NYSE:GMRE) posted its quarterly earnings results on Wednesday, May, 4th. The company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.23 by $0.19. Global Medical REIT had a net margin of 13.31% and a trailing twelve-month return on equity of 2.96%. During the same quarter last year, the company earned $0.24 EPS.

How often does Global Medical REIT pay dividends? What is the dividend yield for Global Medical REIT?

Global Medical REIT declared a quarterly dividend on Friday, June 10th. Stockholders of record on Friday, June 24th will be given a dividend of $0.21 per share on Friday, July 8th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 7.15%. The ex-dividend date of this dividend is Thursday, June 23rd.
Read our dividend analysis for GMRE
.

Is Global Medical REIT a good dividend stock?

Global Medical REIT (NYSE:GMRE) pays an annual dividend of $0.84 per share and currently has a dividend yield of 7.13%. GMRE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 442.13%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, GMRE will have a dividend payout ratio of 81.55% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for GMRE.

What other stocks do shareholders of Global Medical REIT own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include Principal Financial Group (PFG), INSYS Therapeutics (INSY), General Electric (GE), New Residential Investment (NRZ), AT&T (T), Big Lots (BIG), Block (SQ), Energy Transfer (ET), Medical Properties Trust (MPW) and AGNC Investment (AGNC).

When did Global Medical REIT IPO?

(GMRE) raised $130 million in an initial public offering (IPO) on Wednesday, June 29th 2016. The company issued 13,000,000 shares at $10.00 per share. Wunderlich and Oppenheimer served as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

What is Global Medical REIT's stock symbol?

Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."

Who are Global Medical REIT's major shareholders?

Global Medical REIT's stock is owned by a variety of institutional and retail investors. Top institutional investors include Brown Advisory Inc. (1.91%), Aew Capital Management L P (1.52%), State of New Jersey Common Pension Fund D (1.50%), Allspring Global Investments Holdings LLC (0.62%), Sound Income Strategies LLC (0.60%) and Monarch Partners Asset Management LLC (0.33%). Insiders that own company stock include Henry Cole, Jeffrey Busch and Ronald Marston.
View institutional ownership trends
.

How do I buy shares of Global Medical REIT?

Shares of GMRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Global Medical REIT's stock price today?

One share of GMRE stock can currently be purchased for approximately $11.75.

How much money does Global Medical REIT make?

Global Medical REIT (NYSE:GMRE) has a market capitalization of $769.84 million and generates $115.94 million in revenue each year. The company earns $17.62 million in net income (profit) each year or $0.19 on an earnings per share basis.

How many employees does Global Medical REIT have?

Global Medical REIT employs 26 workers across the globe.

How can I contact Global Medical REIT?

Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The official website for the company is www.globalmedicalreit.com. The company can be reached via phone at (202) 524-6851 or via email at investors@globalmedicalreit.com.

This page (NYSE:GMRE) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.